norethindrone has been researched along with Neoplasms in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (72.41) | 18.7374 |
| 1990's | 1 (3.45) | 18.2507 |
| 2000's | 2 (6.90) | 29.6817 |
| 2010's | 4 (13.79) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Arkenau, HT; Chitnis, S; De Vos-Geelen, J; Ilankumaran, P; Llacer-Perez, C; Moore, K; Nidamarthy, PK; Taylor, D; Xu, X | 1 |
| Freeman, S; Shulman, LP | 1 |
| Eiken, P; Jensen, JE; Køber, L; Mosekilde, L; Rejnmark, L; Schierbeck, LL; Stilgren, L; Tofteng, CL | 1 |
| Colburn, D; Colevas, AD; Graham, RA; LoRusso, PM; Low, JA; Malhi, V; Mita, M; Piha-Paul, SA; Yin, M | 1 |
| Meyer, KK | 1 |
| Coppens, M; Thiery, M | 1 |
| Kaunitz, AM | 1 |
| BORY, R; CAPLIER, P | 1 |
| Grant, A | 1 |
| BRISCOE, CC | 1 |
| JACOBSON, L | 1 |
| PRAKASH, S; SCULLY, RE | 1 |
| CRAIG, JM; KISTNER, RW; STEINER, GJ | 1 |
| SOOST, HJ | 1 |
| Fraser, IS; Weisberg, E | 1 |
| Schardein, JL | 1 |
| Herman, JR; Maier, WE | 1 |
| Anderson, CS; Need, AG; Olweny, CL | 1 |
| Keller, PJ | 1 |
| Dendy, PP | 1 |
| Ostergaard, E | 1 |
| Gaudin, D; Guthrie, L; Yielding, KL | 1 |
| Preece, AW; Proud, AJ | 1 |
8 review(s) available for norethindrone and Neoplasms
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Considerations for the use of progestin-only contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Counseling; Desogestrel; Drug Prescriptions; Family Planning Services; Female; Health Promotion; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Patient Education as Topic; Patient Selection; Pregnancy, Unplanned; Progesterone Congeners; Risk Factors; United States | 2010 |
[GYNECOLOGY].
Topics: Abortion, Threatened; Ascites; Capillary Resistance; Endometriosis; Estriol; Estrogens; Female; Genital Neoplasms, Female; Glycoside Hydrolases; Gold Isotopes; Gonadal Steroid Hormones; Gonadotropins; Gynecology; Humans; Menopause; Neoplasms; Norethindrone; Norethynodrel; Ovarian Neoplasms; Polycystic Ovary Syndrome; Pregnancy; Pregnanediol; Progesterone; Progestins; Uterine Prolapse | 1963 |
[PERORAL GESTAGEN/ESTROGEN TREATMENT--A SURVEY TOGETHER WITH PERSONAL CLINICAL TRIALS OF THE PREPARATION ANOVLAR].
Topics: Acne Vulgaris; Biomedical Research; Contraceptives, Oral; Drug Combinations; Dysmenorrhea; Endocrinology; Endometriosis; Estrogens; Ethinyl Estradiol; Female; Fetal Diseases; Humans; Liver Diseases; Neoplasms; Norethindrone; Pharmacology; Premenstrual Syndrome; Progestins | 1964 |
A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate.
Topics: Australia; Blood Pressure; Breast Neoplasms; Contraceptives, Oral; Drug Implants; Female; Fertility; Fetus; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Thrombophlebitis; Uterine Cervical Neoplasms | 1981 |
Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals.
Topics: Animals; Animals, Laboratory; Contraceptives, Oral; Dogs; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Haplorhini; In Vitro Techniques; Mice; Mutagens; Neoplasms; Norethindrone; Norethindrone Acetate; Rats; Species Specificity; Teratogens; Toxicity Tests | 2001 |
[Hormonal contraception using depot preparations].
Topics: Abnormalities, Drug-Induced; Blood Coagulation; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levonorgestrel; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Pregnancy; Risk | 1986 |
2 trial(s) available for norethindrone and Neoplasms
| Article | Year |
|---|---|
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.
Topics: Breast Neoplasms; Contraceptives, Oral, Synthetic; Denmark; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Follow-Up Studies; Heart Failure; Hormone Replacement Therapy; Hospitalization; Humans; Middle Aged; Myocardial Infarction; Neoplasms; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Risk; Stroke; Time Factors; Treatment Outcome; Venous Thrombosis | 2012 |
Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential.
Topics: Aged; Anilides; Antineoplastic Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cohort Studies; Contraceptives, Oral, Combined; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Drug Interactions; Ethinyl Estradiol; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Norethindrone; Pyridines; Rosiglitazone; Thiazolidinediones | 2013 |
19 other study(ies) available for norethindrone and Neoplasms
| Article | Year |
|---|---|
Pharmacokinetic Interaction Between the MEK1/MEK2 Inhibitor Trametinib and Oral Contraceptives Containing Norethindrone and Ethinyl Estradiol in Female Patients With Solid Tumors.
Topics: Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Male; Neoplasms; Norethindrone; Pyridones; Pyrimidinones | 2022 |
Injectable contraceptives: safe and effective.
Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Family Planning Services; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Politics | 1982 |
Breast cancer manifest during contraceptive steroid therapy of two women with prior lactation mastitis.
Topics: Breast; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dimethisterone; Disease; Ethinyl Estradiol; Family Planning Services; Lactation; Neoplasms; Norethindrone; Puerperal Disorders; Research | 1969 |
Statement on injectable contraception.
Topics: Animals, Laboratory; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endometrial Neoplasms; Family Planning Services; Injections; International Agencies; Lactation; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Organizations; Research; Steroids; Uterine Cervical Neoplasms | 1982 |
Endometrial response to the use of a sequential oral contraceptive.
Topics: Anatomy; Belgium; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Disease; Endocrine System; Endometrial Neoplasms; Endometrium; Europe; Family Planning Services; Genitalia; Genitalia, Female; Histology; Hormones; Mestranol; Neoplasms; Norethindrone; Physiology; Reproductive Control Agents; Risk Factors; Urogenital System; Uterus | 1988 |
Injectable contraception: the USA perspective.
Topics: Americas; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Endometrial Neoplasms; Evaluation Studies as Topic; Family Planning Services; Government Agencies; Health Services Accessibility; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; North America; Organizations; United States; United States Food and Drug Administration; United States Public Health Service | 1992 |
AN EVALUATION OF THE CONSERVATIVE TREATMENT OF ENDOMETRIOSIS.
Topics: Amenorrhea; Endometriosis; Ethinyl Estradiol; Female; Humans; Nausea; Neoplasms; Norethindrone; Pregnancy; Pregnancy Complications; Statistics as Topic; Surgical Procedures, Operative; Toxicology; Uterine Hemorrhage | 1963 |
ACUTE HEMORRHAGIC DEGENERATION OF A LEIOMYOMA FOLLOWING NORETHINDRONE ACETATE: REPORT OF A CASE.
Topics: Female; Humans; Leiomyoma; Neoplasms; Norethindrone; Norethindrone Acetate; Pathology; Surgical Procedures, Operative; Toxicology; Uterine Neoplasms | 1964 |
SARCOMA-LIKE PSEUDOPREGNANCY. CHANGES IN UTERINE LEIOMYOMAS. REPORT OF A CASE RESULTING FROM PROLONGED NORETHINDRONE THERAPY.
Topics: Appendectomy; Female; Humans; Hysterectomy; Leiomyoma; Neoplasms; Norethindrone; Pathology; Pregnancy; Pseudopregnancy; Sarcoma; Toxicology; Uterine Neoplasms | 1964 |
HISTOLOGICAL EFFECTS OF PROGESTINS ON HYPERPLASIA AND CARCINOMA IN SITU OF THE ENDOMETRIUM--FURTHER OBSERVATIONS.
Topics: Carcinoma in Situ; Drug Therapy; Endometrial Hyperplasia; Endometrium; Female; Geriatrics; Humans; Hydroxyprogesterones; Hyperplasia; Hysterectomy; Medroxyprogesterone; Menopause; Mestranol; Neoplasms; Norethindrone; Norethynodrel; Pathology; Progestins; Uterine Neoplasms | 1963 |
[COLPOSCOPIC, CYTOLOGIC AND HISTOLOGIC FINDINGS IN THE PORTIO UTERI DURING OVULATION INHIBITING MEDICATION].
Topics: Cervix Uteri; Colposcopy; Contraceptive Agents; Contraceptives, Oral; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Mestranol; Neoplasms; Norethindrone; Norethynodrel; Ovulation; Pregnancy; Toxicology; Uterine Cervical Neoplasms; Vaginal Smears | 1965 |
Injectable hormonal contraceptives: technical and safety aspects.
Topics: Adolescent; Adult; Animals; Contraceptive Agents, Female; Dogs; Drug Labeling; Family Planning Services; Female; Fertility; Haplorhini; Humans; Injections, Intramuscular; Medroxyprogesterone; Menstruation Disturbances; Neoplasms; Norethindrone; Rats | 1982 |
Studies of the components of an oral contraceptive agent in albino rats. II. Progestogenic component and comparison of effects of the components and the combined agent.
Topics: Alopecia; Animals; Body Weight; Eating; Female; Genitalia; Liver; Liver Neoplasms; Longevity; Male; Neoplasms; Norethindrone; Rats | 1980 |
Treatment of malignancy-associated hypercalcemia with norethisterone: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Hypercalcemia; Middle Aged; Neoplasms; Norethindrone; Prednisone; Vincristine | 1989 |
Responses of freshly cultured tumour cells to certain selected chemotherapeutic agents.
Topics: Adenocarcinoma; Antineoplastic Agents; Chlorambucil; Colchicine; Culture Techniques; Cyclophosphamide; Dactinomycin; Female; Floxuridine; Fluorouracil; Hodgkin Disease; Humans; Melphalan; Mercaptopurine; Methotrexate; Nandrolone; Neoplasms; Nitrogen Mustard Compounds; Norethindrone; Prednisolone; Progesterone; Testosterone; Thiotepa; Uterine Neoplasms; Vinblastine | 1968 |
Oral anticonception. Side effects and risks.
Topics: Acne Vulgaris; Contraceptives, Oral; Depression; Estrogens; Feeding and Eating Disorders; Female; Hair; Headache; Humans; Leukorrhea; Libido; Liver; Lynestrenol; Megestrol; Menstruation Disturbances; Mestranol; Nausea; Neoplasms; Norethindrone; Norethynodrel; Obesity; Ovulation; Premenstrual Syndrome; Progesterone; Skin; Thrombophlebitis; Vagina; Veins; Voice; Water-Electrolyte Balance | 1969 |
Norethindrone--the "minipill".
Topics: Contraceptives, Oral; Female; Humans; Menstruation; Neoplasms; Norethindrone; Pregnancy | 1973 |
DNA repair inhibition: a new mechanism of action of steroids with possible implications for tumor therapy.
Topics: Contraceptives, Oral; Diethylstilbestrol; Dihydrotestosterone; DNA; DNA Repair; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Lymphocytes; Medroxyprogesterone; Neoplasms; Norethindrone; Norethynodrel; Progesterone; Testosterone; Thymidine; Tritium | 1974 |
Measurement and treatment of mammary carcinoma in bitches.
Topics: Androgens; Animals; Dog Diseases; Dogs; Estrogens; Female; Mammary Glands, Animal; Neoplasms; Norethindrone; Progesterone | 1971 |